References
- StuppRHegiMEMasonWPEffects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trialLancet Oncol200910545946619269895
- CarrilloJALaiANghiemphuPLRelationship between tumor enhancement, edema, IDH1 mutational status, MGMT promoter methylation, and survival in glioblastomaAJNR Am J Neuroradiol20123371349135522322613
- VermaVMehtaMPClinical ramifications of “genomic staging” of low-grade gliomasJ Neurooncol2016129219519927401152
- GebhardtBJDobelbowerMCEnnisWHBagAKMarkertJMFiveashJBPatterns of failure for glioblastoma multiforme following limited-margin radiation and concurrent temozolomideRadiat Oncol2014913024906388
- WellerMFelsbergJHartmannCMolecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma NetworkJ Clin Oncol200927345743575019805672
- ChenJRYaoYHzXQinZYIsocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With GlioblastomasMedicine (Baltimore)2016959e258326945349
- HegiMELiuLHermanJGCorrelation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activityJ Clin Oncol200826254189419918757334
- LasockiAGaillardFTaceyMDrummondKStuckeySMultifocal and multicentric glioblastoma: Improved characterisation with FLAIR imaging and prognostic implicationsJ Clin Neurosci201631929827343042
- PatilCGYiAElramsisyAPrognosis of patients with multifocal glioblastoma: a case-control studyJ Neurosurg2012117470571122920963
- HassaneenWLevineNBSukiDMultiple craniotomies in the management of multifocal and multicentric glioblastoma. Clinical articleJ Neurosurg2011114357658420690813
- ZamponiNRychlickiFDucatiARegnicoloLSalvoliniURicciutiRAMulticentric glioma with unusual clinical presentationChilds Nerv Syst2001171–210110511219614
- SinghGMehrotraASardharaJMultiple glioblastomas: Are they different from their solitary counterparts?Asian J Neurosurg201510426627126425153
- WenPYMacdonaldDRReardonDAUpdated response assessment criteria for high-grade gliomas: response assessment in neurooncology working groupJ Clin Oncol201028111963197220231676
- PaulssonAKHolmesJAPeifferAMComparison of clinical outcomes and genomic characteristics of single focus and multifocal glioblastomaJ Neurooncol2014119242943524990827
- ShowalterTNAndrelJAndrewsDWCurranWJJrDaskalakisCWerner-WasikMMultifocal glioblastoma multiforme: prognostic factors and patterns of progressionInt J Radiat Oncol Biol Phys200769382082417499453
- ThomasRPXuLWLoberRMLiGNagpalSThe incidence and significance of multiple lesions in glioblastomaJ Neurooncol20131121919723354652
- SahmFCapperDJeibmannAAddressing diffuse glioma as a systemic brain disease with single-cell analysisArch Neurol201269452352622158715
- OsswaldMJungESahmFBrain tumour cells interconnect to a functional and resistant networkNature2015528758093826536111
- TombalBDenmeadeSRGillisJMIsaacsJTA supramicromolar elevation of intracellular free calcium ([Ca(2+)](i)) is consistently required to induce the execution phase of apoptosisCell Death Differ20029556157311973614
- LiuQLiuYLiWGenetic, epigenetic, and molecular landscapes of multifocal and multicentric glioblastomaActa Neuropathol2015130458759726323991
- Abou-El-ArdatKSeifertMBeckerKComprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomasNeuro Oncol201719454655728201779